CF files 8-K — Item 2.02 Results of Operations

CF Industries Holdings, Inc. filed an 8-K disclosing Item 2.02 (Results of Operations and Financial Results) with the SEC on May 6, 2026, at 16:51:45 ET.

What Was Filed

Per SEC plain-language rules, Item 2.02 filings are used to furnish material non-public information about quarterly or annual financial results to public investors. The lead item in this 8-K is Item 2.02, with the filing including an attached exhibit (EDGAR accession number 000110465926056338) containing the company’s Q1 2026 earnings announcement. A second identical 8-K was filed the same day with the official full earnings exhibit (accession 000132440426000011). This filing follows two prior 8-K submissions on May 4 and 5, including the May 5 appointment of Andrew T. Scribner as executive vice president and chief financial officer.

The Disclosure

For basic materials firms in the agricultural inputs sector, Item 2.02 filings typically include top-line revenue, net income, adjusted EBITDA, and contextual remarks on global market conditions for nitrogen and hydrogen products. The referenced May 6 Business Wire headline confirms the filing includes Q1 2026 net earnings of $615 million and adjusted EBITDA of $983 million, though full standardized financial line items are only accessible via the attached EDGAR exhibit.

Cross-Referenced Prior Signals

This earnings filing follows a batch of equity awards granted to insiders on April 30, 2026, via Form 4 filings: seven independent directors received 1,390 stock awards each, director Anne P. Noonan received 2,208 awards, and SVP Manufacturing & Distribution Trevor Leigh Williams received 4,184 awards, all at no cash cost to the recipients. Analyst ratings for CF Industries have remained static since March 2026, with 1 Strong Buy, 2 Buy, 15 Hold, 2 Sell, and 1 Strong Sell ratings posted as of May 1, 2026, with no shifts in distribution over the prior two months. As of December 31, 2025, the $19.7 billion market cap company had 844 institutional holders (a net increase of 3), holding 99% of its float, with 389 institutions increasing positions and 307 reducing positions in the prior quarter.

Unstated Critical Data Points

1. Exact diluted EPS and total Q1 2026 revenue figures: the provided earnings history only lists consensus estimates ($2.63 EPS, ~$1.84 billion revenue) with no actual reported values from this filing.

2. Segment-level operating performance, including revenue and margins for core products like anhydrous ammonia and urea, to assess demand shifts in global agricultural inputs markets.

3. Forward-looking guidance for Q2 2026 or full-year 2026, a standard component of Item 2.02 filings that would inform near-term valuation metrics for the firm.